Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 24, 2013
Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitusMichael Feher, Mark Greener, Neil Munro
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 1, 2017
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)Andrew McGovern, Michael Feher, Neil Munro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2020
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?William Hinton, Michael Feher, Neil Munro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 2, 2018
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study ProtocolWilliam Hinton, Michael Feher, Neil Munro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 22, 2017
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World UseAndrew McGovern, Michael Feher, Neil Munro, et al.
Plos One|January 11, 2019
Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practiceRachel Coyle, Michael Feher, Simon Jones, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
Diabetes, obesity and COVID-19: A complex interplayPrashanth Vas, David Hopkins, Michael Feher, et al.
Diabetes, Obesity & Metabolism|March 23, 2019
Real-world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice networkWilliam Hinton, Michael Feher, Neil Munro, et al.
BMJ Health & Care Informatics|October 22, 2020
Atrial fibrillation dashboard evaluation using the think aloud protocolSimon de Lusignan, Harshana Liyanage, Julian Sherlock, et al.
JMIR Research Protocols|July 19, 2022
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)Michael Feher, William Hinton, Anna Forbes, et al.
Pageof 4